MCO

structure

Also Known As:

(6R,7R)-7-((2R)-2-hydroxy-2-phenylacetamido)-3-(pyrid-2-yl-N-oxide)thiomethylceph-3-em 4-carboxylic acid; (6R-(6 alpha,7 beta(R)))-7-((hydroxyphenylacetyl)amino)-8-oxo-3-((2-pyridinylthio) methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid monooxide

Networked: 286 relevant articles (14 outcomes, 52 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        MCO: 286
- Sulfur Compounds: 278
  - Thiazines: 3
    - Cephalosporins: 4007
      - MCO: 286
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        MCO: 286

Experts

1.	Ronco, Claudio: 6 articles (01/2022 - 01/2018)
2.	Singh, Sarbhan: 4 articles (01/2022 - 07/2020)
3.	Schindler, Ralf: 4 articles (01/2021 - 01/2017)
4.	Willy, Kevin: 4 articles (01/2021 - 01/2017)
5.	Zickler, Daniel: 4 articles (01/2021 - 01/2017)
6.	Hulko, Michael: 4 articles (01/2018 - 01/2017)
7.	Storr, Markus: 4 articles (01/2018 - 01/2017)
8.	Craft, David: 4 articles (11/2017 - 01/2013)
9.	Sharip, Shalisah: 3 articles (02/2022 - 11/2020)
10.	Sidi, Hatta: 3 articles (02/2022 - 12/2020)

Related Diseases

1.	COVID-19 01/01/2023 - "However, due to the COVID-19 pandemic, our results suggest that the MCO membrane may be beneficial in chronic HD patients with COVID-19." 01/01/2021 - "In addition, more stringent movement control measures such as the MCO and CMCO were effective for further lowering the R-value and case numbers during the third wave of the COVID-19 pandemic in Malaysia due to their higher stringency than the nationwide RMCO." 05/01/2023 - "This study aimed to classify the spatiotemporal analysis of rainwater quality before and during the Movement Control Order (MCO) implementation due to the COVID-19 pandemic. " 01/01/2023 - "This study provides insights into the experiences, coping strategies and perspectives of people in Malaysia living through the first-ever MCO during the COVID-19 pandemic. " 10/01/2022 - "A total of 535 individuals aged 52 years and above from the previous cohort and interventional studies in Peninsular Malaysia were contacted during the Movement Control Order (MCO) issued during the COVID-19 pandemic. "
2.	Uremia 01/01/2018 - "High IF combined with enhanced sieving profile of MCO membrane leads to improved removal of a wider spectrum of uremia retention molecules in HDx, without requiring complex equipment." 01/01/2023 - "Uremia downmodulates vasculoprotective KLF2 in endothelium, leading to detrimental vascular inflammation, while MCO dialysis with the novel improved HDx therapy approach can maintain physiological levels of vasculoprotective KLF2."
3.	Neoplasms (Cancer) 09/15/2023 - "From the French national hospital database (PMSI-MCO), every hospitalization in French hospitals for renal tumor PN in 2016-2017 were extracted. " 01/17/2022 - "(3) RESULTS: 1071 patients were included, 852 (79.6%) presented benign/borderline tumors and 219 (20.4%) presented EOC/MCO. " 01/01/2022 - "With integration into existing systems, online platforms (such as MCO) could provide efficient and patient-centred information for those providing care for people with cancer." 01/01/2020 - "The results demonstrated that G0/G1 to S-phase arrest and increased apoptosis may contribute to the proliferation inhibition by rFIP-mco in the two cancer cells. " 01/01/2020 - "In order to explore the potential mechanism of the cytotoxicity effect of rFIP-mco on A549 and HepG2 cells, cell cycle and apoptosis assay in the two cancer cells were conducted. "
4.	Inflammation (Inflammations) 01/01/2020 - "Feeding O. niloticus on the HCO diet increased innate immunity and reduced pathogenic bacteria, pro-inflammation, hepatotoxicity, cellular stress and apoptosis than the MCO diet. " 01/01/2017 - "MCO-Ci dialyzers modulate inflammation in chronic HD patients to a greater extent compared to High-flux dialyzers. " 01/01/2017 - "Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial." 04/01/2016 - "Our data showed that MCO shortened the inflammation phase by provoking the fibroblast proliferation. " 01/01/2021 - "To date, no study has combined the use of an MCO membrane and fiber supplementation to reduce PBUT levels and inflammation with online hemodiafiltration as a comparator. "
5.	Wounds and Injuries (Trauma) 04/01/2016 - "Hydroethanolic extract of MCO significantly (p < 0.05) increased wound contraction percentage. " 01/01/2011 - "Part II explains MCOs' use of utilization review to contain costs and analyzes the manner in which courts have addressed the issue of MCO liability for patient injuries sustained from denial ofcoverage. " 07/01/2002 - "Efforts to control injuries within managed care organization (MCO) populations require information about the incidence and costs associated with the injuries cared for in MCOs. " 04/01/2001 - "Changes in the Medicare reimbursement system for home health care may have provided an equalizing effect between Medicare MCO and traditional Medicare patients with wound/skin diagnoses in home health care agencies in the Midwest." 08/01/2002 - "The concurrent data collection processes used in the MCO program for performance measurement of resuscitation efforts, intubations, submersion incidents and aeromedical transports for trauma cases have been very effective in the integration of data from multiple computer databases and telephone follow-ups with field crews and receiving emergency department staffs. "

Related Drugs and Biologics

1.	Cytokines
2.	Oxidants (Oxidizing Agents)
3.	Platinum
4.	STA 9090
5.	Proteins (Proteins, Gene)
6.	Metals
7.	Interleukin-6 (Interleukin 6)
8.	omega-Chloroacetophenone (Mace)
9.	Synucleins
10.	Ranitidine (Zantac)

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)
2.	Therapeutics
3.	Drug Therapy (Chemotherapy)
4.	Resuscitation
5.	Continuous Renal Replacement Therapy